Lenalidomide and its role in the management of multiple myeloma. - Wikidata - wikimedia - TriplyDB

Lenalidomide and its role in the management of multiple myeloma.

Lenalidomide and its role in the management of multiple myeloma.

http://www.wikidata.org/entity/Q37183439

about

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma Trace determination of lenalidomide in plasma by non-extractive HPLC procedures with fluorescence detection after pre-column derivatization with fluorescamine.Anti-inflammatory Agents: Present and Future Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.Pain management in multiple myeloma.Development and validation of ultra-performance liquid chromatographic method with tandem mass spectrometry for determination of lenalidomide in rabbit and human plasma A highly sensitive fluorimetric method for determination of lenalidomide in its bulk form and capsules via derivatization with fluorescamine.

P2860

Q33756369-3EA57981-8960-4AB8-B453-436C390DC5AD Q35121026-F5D4D529-7746-487A-9DA0-71CD7BE92473 Q36394469-BEFB0EE9-4DB8-45AD-9D53-21B91D66D723 Q36744385-B13F48D2-01DE-4D72-BB44-2491EC046A5E Q37118156-837E6068-2804-49A8-A28A-DD08DD16282B Q37215121-1D6BBC17-9E11-4B34-8F55-CFF84BA7084F Q37375005-58815446-B2DE-488B-B926-4330C6CA4244 Q37705421-F8882730-D9F5-444D-9EB1-9843ED195311 Q39305248-3B095264-98CB-431A-B455-24CFE389FE57 Q42534665-9D700C0C-0493-43C4-95AC-C12AC4CFEA15

P2860

Lenalidomide and its role in the management of multiple myeloma.

http://www.wikidata.org/entity/Q37183439

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lenalidomide and its role in the management of multiple myeloma.

@en

Lenalidomide and its role in the management of multiple myeloma.

@nl

type

label

Lenalidomide and its role in the management of multiple myeloma.

@en

Lenalidomide and its role in the management of multiple myeloma.

@nl

prefLabel

Lenalidomide and its role in the management of multiple myeloma.

@en

Lenalidomide and its role in the management of multiple myeloma.

@nl

P1433

Q37183439-0206F7F7-7C3D-4276-83DB-7431BDC36AA3

P1476

Q37183439-38E82BBD-E635-4506-9F0D-F82C941022FF

P2093

Q37183439-185C43C6-AC88-4311-8111-0CB940C8B0A0

Q37183439-25B1BFC7-C9DC-4A3A-9E69-7695F6E2E8DF

Q37183439-6E0457E2-A5C1-434C-9964-E60FCFAC736A

P2860

Q37183439-11562EE2-0AFC-4210-9277-987E641AE76A

Q37183439-11773A29-DF55-4F30-AE03-C5341BBEE38F

Q37183439-2C9F2A93-D94E-4DA9-AD0E-9EB011D2690E

Q37183439-3A292A01-5774-4855-AC96-6A5C36FD1BF3

Q37183439-3C42A16D-B047-4F0C-B180-22CC5F91EDF3

Q37183439-49A20F72-4416-4B2D-85F2-B70447E6CB56

Q37183439-49AD11AD-1CA9-4DE6-AD5C-382A2F7C1C9A

Q37183439-4B6B1EC7-14F8-4ADA-B626-255B1776D095

Q37183439-560BA878-9368-45EC-97FD-972A03671539

Q37183439-617ACEEF-FE26-47A1-94AC-A5FDECDB4F51

P304

Q37183439-F7298C6A-505E-47D0-9D3C-3A1ED1150020

P31

Q37183439-0B2D567A-C484-4C62-8E7C-2F8A7ABEC082

P356

Q37183439-E3C1A4D6-2001-44BA-A53E-288F4F527B28

P433

Q37183439-4A390CD7-EB89-4379-8AE0-B2F3DB112283

P478

Q37183439-DD33950F-7928-4EA0-8470-E6FDE70D7BD0

P50

Q37183439-4B60D9A0-BD2F-487D-9A34-20212BC8888A

Q37183439-510D5FE2-A5EE-4F97-9EB6-BC815AD89E6A

Q37183439-6714F680-1443-4CB5-A74E-0BB015785699

Q37183439-680E2A46-FAEA-4119-9D8C-623DEC588D16

P577

Q37183439-FBCB6B54-D5B9-4985-9414-1A747A4BCD1B

P698

Q37183439-C644693D-5AF5-4741-98ED-058798A4683C

P356

14737140.8.6.865

P1433

Expert Review of Anticancer Therapy

P1476

Lenalidomide and its role in the management of multiple myeloma.

@en

P2093

Anna Marina Liberati

http://www.w3.org/2001/XMLSchema#string

Mario Boccadoro

http://www.w3.org/2001/XMLSchema#string

Patrizia Falco

http://www.w3.org/2001/XMLSchema#string

P2860

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection

Risk of thrombosis with lenalidomide and its prevention with aspirin

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Antitumor activity of thalidomide in refractory multiple myeloma.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Multiple Myeloma. Advances in disease biology: therapeutic implications.

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.

P304

865-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.6.865

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Pellegrino Musto

Alessandra Larocca

Federica Cavallo

Antonio Palumbo

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18533796

http://www.w3.org/2001/XMLSchema#string